Humanwell Healthcare Financials

Market Capitalization CN¥35.26 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	25.41
Forward PE	14.12
Price to Sales TTM	CN¥1.40
Price to Book MRQ	CN¥1.95
Enterprise to Revenue	1.69
Enterprise to EBITDA	10.92

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	5.49%
Operating Margin	14.59%
Return on Assets TTM	5.10%
Return on Equity TTM	8.77%

Income Statement

Revenue TTM	CN¥25,205,512,192
Revenue per Share TTM	CN¥15.51
Quarterly Revenue Growth	-3.60%
Gross Profit TTM	CN¥11,337,834,496
EBITDA	CN¥3,348,382,107
Net Income to Common TTM	CN¥1,383,698,432
Diluted EPS TTM	CN¥0.85
Quarterly Earnings Growth YoY	11.10%

Balance Sheet

Total Cash MRQ	CN¥4,587,838,976
Total Cash per Share MRQ	CN¥2.80
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	44.99
Current Ratio MRQ	1.49
Book Value per Share MRQ	CN¥11.08

Cash Flow

Operating Cash Flow TTM	CN¥2,006,981,376
Levered Free Cash Flow TTM	CN¥870,877,888

600079 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	1,632,225,965
Float Shares	1,401,688,876
Avg 10 Volume	14,917,523
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	39.49%
% Held by Institutions	18.19%

Stock Price Summary

Beta	0.64
Fifty Two Week Low	CN¥15.68
Fifty Two Week High	CN¥25.90
Fifty Two Week Change	22.36%
Day 50 MA	CN¥20.98
Day 200 MA	CN¥21.40

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.60
Forward Annual Dividend Yield	2.81%
Trailing Annual Dividend Rate	CN¥0.15
Trailing Annual Dividend Yield	0.70%
Payout Ratio	71.76%
Dividend Date
Ex Dividend Date	2024-10-11
Last Split Factor
Last Split Date	2015-07-22